EUVIMEDEUVIMED entdecken
Open Access

Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia

Keith Dodd, Kristina T Legget, Marc-Andre Cornier, Andrew M Novick, Maureen McHugo, Brian D Berman, Benjamin P Lawful, Jason R Tregellas

Schizophrenia Research · 2024

DOI: 10.1016/j.schres.2024.03.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Keith Dodd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Anschutz Health Sciences Building, 1890 N Revere Ct, Au…. Hauptthemen laut MEDLINE: Schizophrenia, Magnetic Resonance Imaging, Antipsychotic Agents, Weight Gain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The mechanisms by which antipsychotic medications (APs) contribute to obesity in schizophrenia are not well understood. Because AP effects on functional brain connectivity may contribute to weight effects, the current study investigated how AP-associated weight-gain risk relates to functional connectivity in schizophrenia. METHODS: Fifty-five individuals with schizophrenia (final N = 54) were divided into groups based on previously reported AP weight-gain risk (no APs/low risk [N = 19]; moderate risk [N = 17]; high risk [N = 18]). Resting-state functional magnetic resonance imaging (fMRI) was completed after an overnight fast ("fasted") and post-meal ("fed"). Correlations between AP weight-gain risk and functional connectivity were assessed at the whole-brain level and in reward- and eating-related brain regions (anterior insula, caudate, nucleus accumbens). RESULTS: When fasted, greater AP weight-gain risk was associated with increased connectivity between thalamus and sensorimotor cortex (pFDR = 0.021). When fed, greater AP weight-gain risk was associated with increased connectivity between left caudate and left precentral/postcentral gyri (pFDR = 0.048) and between right caudate and multiple regions, including the left precentral/postcentral gyri (pFDR = 0.001), intracalcarine/precuneal/cuneal cortices (pFDR < 0.001), and fusiform gyrus (pFDR = 0.008). When fed, greater AP weight-gain risk was also associated with decreased connectivity between right anterior insula and ventromedial prefrontal cortex (pFDR = 0.002). CONCLUSIONS: APs with higher weight-gain risk were associated with greater connectivity between reward-related regions and sensorimotor regions when fasted, perhaps relating to motor anticipation for consumption. Higher weight-gain risk APs were also associated with increased connectivity between reward, salience, and visual regions when fed, potentially reflecting greater desire for consumption following satiety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaMagnetic Resonance ImagingAntipsychotic AgentsWeight GainHumansMaleFemaleAdultBrainYoung AdultMiddle AgedRewardNeural PathwaysRiskConnectomeObesity

Stichwörter der Autor:innen

AntipsychoticsFunctional connectivityObesitySchizophreniaWeight-gainfMRI

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Anschutz Health Sciences Building, 1890 N Revere Ct, Aurora, CO 80045, USA; Department of Bioengineering, University of Color…
  • Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Anschutz Health Sciences Building, 1890 N Revere Ct, Aurora, CO 80045, USA; Research Service, Rocky Mountain Regional VA Medi…
  • Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, Clinical Sciences Building, CSB 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
  • Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Anschutz Health Sciences Building, 1890 N Revere Ct, Aurora, CO 80045, USA.
  • Department of Neurology, Virginia Commonwealth University, 1101 E Marshall Street, Richmond, VA 23298, USA.

Förderung

  • NICHD NIH HHS
  • NIDDK NIH HHS
  • NIA NIH HHS
  • CSRD VA
  • NIMH NIH HHS
  • National Institutes of Health

Zitieren

APA

Dodd, K., Legget, K. T., Cornier, M. A., Novick, A. M., McHugo, M., Berman, B. D., Lawful, B. P., & Tregellas, J. R. (2024). Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.03.033

Vancouver

Dodd K, Legget KT, Cornier MA, Novick AM, McHugo M, Berman BD, et al. Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.03.033

BibTeX
@article{Dodd2024,
  author = {Dodd, Keith and Legget, Kristina T and Cornier, Marc-Andre and Novick, Andrew M and McHugo, Maureen and Berman, Brian D and Lawful, Benjamin P and Tregellas, Jason R},
  title = {Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia},
  journal = {Schizophrenia Research},
  year = {2024},
  doi = {10.1016/j.schres.2024.03.033}
}
Kostenlos starten →